Safinamide Mesylate

CHEMBL48582 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

398.5 g/mol

LogP

—

Phase

4

A mesylate salt form of safinamide with the same therapeutic properties. Taken as an add-on to levodopa therapy, this medication helps smooth out the motor fluctuations that Parkinson's patients experience as their levodopa dose wears off.

Peso Molecular

398,5000 g/mol

TPSA

127,00 Å²

Áreas Terapêuticas

Parkinson's Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)O.C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O

InChI

InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1

Molecular Formula

C18H23FN2O5S

HBD / HBA

3 / 7

Ligações Rotacionáveis

7

Átomos Pesados

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A mesylate salt form of safinamide with the same therapeutic properties. Taken as an add-on to levodopa therapy, this medication helps smooth out the motor fluctuations that Parkinson's patients experience as their levodopa dose wears off.

Yes, Safinamide Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL48582. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3038502. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Safinamide Mesylate no PillFYI

Estrutura

Dados Rápidos

Fórmula: C18H23FN2O5S
Sinônimos: 1

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.